Targeted therapy and drug resistance in thyroid cancer
Y Zhang, Z Xing, T Liu, M Tang, L Mi, J Zhu… - European Journal of …, 2022 - Elsevier
Thyroid cancer is the most common endocrine malignancy, the incidence of which has
increased significantly over the past decades. Advanced thyroid cancers, especially locally …
increased significantly over the past decades. Advanced thyroid cancers, especially locally …
Cell component and function of tumor microenvironment in thyroid cancer
E Shin, JS Koo - International journal of molecular sciences, 2022 - mdpi.com
Thyroid cancer is the most common cancer in the endocrine system. Most thyroid cancers
have good prognosis, but some of them are resistant to treatment or show aggressive …
have good prognosis, but some of them are resistant to treatment or show aggressive …
[HTML][HTML] The molecular feature of macrophages in tumor immune microenvironment of glioma patients
Background Gliomas are one of the most common types of primary tumors in central nervous
system. Previous studies have found that macrophages actively participate in tumor growth …
system. Previous studies have found that macrophages actively participate in tumor growth …
Single-cell transcriptome analysis reveals inter-tumor heterogeneity in bilateral papillary thyroid carcinoma
T Wang, J Shi, L Li, X Zhou, H Zhang, X Zhang… - Frontiers in …, 2022 - frontiersin.org
Background The tumor microenvironment (TME) plays a pivotal role in cancer progression in
papillary thyroid carcinoma (PTC), yet the composition and the phenotype of cells within the …
papillary thyroid carcinoma (PTC), yet the composition and the phenotype of cells within the …
Dynamic cancer cell heterogeneity: diagnostic and therapeutic implications
V Jacquemin, M Antoine, G Dom, V Detours… - Cancers, 2022 - mdpi.com
Simple Summary Cancer heterogeneity, which occurs in most cancer patients, has been
known and studied by experienced pathologists since the early 19th century. Intratumoral …
known and studied by experienced pathologists since the early 19th century. Intratumoral …
Oxford nanopore MinION direct RNA-seq for systems biology
MA Pyatnitskiy, VA Arzumanian, SP Radko, KG Ptitsyn… - Biology, 2021 - mdpi.com
Simple Summary A new technology has been recently developed by Oxford Nanopore
Technologies, enabling researchers to investigate the structure and relative abundance of …
Technologies, enabling researchers to investigate the structure and relative abundance of …
Inflammation markers have important value in predicting relapse in patients with papillary thyroid carcinoma: a long-term follow-up retrospective study
Y Huang, Y Liu, G Mo, T Zhou, Q Hou, C Shi… - Cancer …, 2022 - journals.sagepub.com
Purpose Many markers of inflammation are increasingly found to have prognostic
significance in some cancers. This study investigated the prognostic value of …
significance in some cancers. This study investigated the prognostic value of …
The immune landscape of papillary thyroid cancer in the context of autoimmune thyroiditis
Simple Summary The association between papillary thyroid cancer and Hashimoto's
thyroiditis went through a long-standing human debate recently elucidated by the …
thyroiditis went through a long-standing human debate recently elucidated by the …
TPO as an indicator of lymph node metastasis and recurrence in papillary thyroid carcinoma
X Li, R Cheng - Scientific Reports, 2023 - nature.com
The objective of this study was to investigate the expression of thyroid peroxidase (TPO) in
papillary thyroid carcinoma (PTC) and to preliminarily investigate its value as a marker of …
papillary thyroid carcinoma (PTC) and to preliminarily investigate its value as a marker of …
Thyroid cancer under the scope of emerging technologies
M Tarabichi, P Demetter, L Craciun, C Maenhaut… - Molecular and cellular …, 2022 - Elsevier
The vast majority of thyroid cancers originate from follicular cells. We outline outstanding
issues at each step along the path of cancer patient care, from prevention to post-treatment …
issues at each step along the path of cancer patient care, from prevention to post-treatment …